Variable Interest Entities - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 22, 2023 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2023 |
|
| Variable Interest Entity [Line Items] | ||||||
| Net assets acquired | $ 600 | |||||
| Liabilities | $ 2,100 | |||||
| Net loss allocated to non-controlling interest | $ 0 | $ 4,313 | $ 268 | $ 6,942 | ||
| Prior PMCo Agreement | Variable Interest Entity, Primary Beneficiary | ||||||
| Variable Interest Entity [Line Items] | ||||||
| Percentage of research and development costs commitments | 65.00% | |||||
| Variable interest entity, ownership percentage | 70.00% | |||||
| Prior PMCo Agreement | Pioneering Medicines 02, Inc | ||||||
| Variable Interest Entity [Line Items] | ||||||
| Percentage of research and development costs commitments | 35.00% | |||||
| Variable interest entity, ownership percentage | 30.00% | |||||
| X | ||||||||||
- Definition Percentage of research and development costs commitments. No definition available.
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|